H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance [Yahoo! Finance]
AngioDynamics, Inc. (ANGO)
Last angiodynamics, inc. earnings: 4/7 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.angiodynamics.com/investor-relations
Company Research
Source: Yahoo! Finance
Wainwright reiterated its Buy rating on AngioDynamics (NASDAQ:ANGO) with a price target of $16, following robust fiscal Q1 2026 results. H.C. Wainwright Reaffirms Buy Rating on AngioDynamics (ANGO) After Strong Q1 Performance The company posted $75.7 million in net sales, up 12.2% year-over-year, driven by a 26.1% surge in Med Tech revenue. Key products like AlphaVac and AngioVac saw sales jump over 50% and 37%, respectively, contributing to a 91% stock return over the past year. Despite a net loss of $10.9 million, AngioDynamics reported positive adjusted EBITDA of $2.2 million. U.S. and international sales rose 11.7% and 15.6%, respectively. The company also raised its full-year guidance, projecting net sales of $308–313 million and adjusted EBITDA of $6.0–10.0 million, while maintaining its gross margin outlook. AngioDynamics, Inc. (NASDAQ:ANGO) is a global medical technology company that develops, produces, and markets devices used in the treatment of peripheral vascular d
Show less
Read more
Impact Snapshot
Event Time:
ANGO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANGO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANGO alerts
High impacting AngioDynamics, Inc. news events
Weekly update
A roundup of the hottest topics
ANGO
News
- AngioDynamics, Inc. (ANGO) Presents at UBS Global Healthcare Conference 2025 Transcript [Seeking Alpha]Seeking Alpha
- AngioDynamics to Participate in the UBS Global Healthcare ConferenceBusiness Wire
- Insider Spends US$112k Buying More Shares In AngioDynamics [Yahoo! Finance]Yahoo! Finance
- AngioDynamics' NanoKnife® System Named to TIME's 2025 Best Inventions List [Yahoo! Finance]Yahoo! Finance
- AngioDynamics’ NanoKnife® System Named to TIME’s 2025 Best Inventions ListBusiness Wire
ANGO
Earnings
- 10/2/25 - Beat
ANGO
Analyst Actions
- 10/3/25 - Canaccord Genuity
ANGO
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 8-K
- 10/22/25 - Form 4
- ANGO's page on the SEC website